Co-Authors
This is a "connection" page, showing publications co-authored by SHI-MING TU and DANIEL D KARP.
Connection Strength
0.141
-
Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial. Invest New Drugs. 2021 10; 39(5):1405-1410.
Score: 0.048
-
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study. NPJ Precis Oncol. 2021 Mar 19; 5(1):21.
Score: 0.048
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.045